First-in-human clinical trial for a vaccine to treat opioid use.
The Pharma Data
SEPTEMBER 7, 2021
Because of its selectivity for oxycodone, the vaccine will not interfere with FDA-approved medications, including methadone, buprenorphine, naltrexone and naloxone, potentially offering a long-lasting, safe and cost-effective alternative that is complementary to standard medical intervention for opioid use disorders.
Let's personalize your content